1. Medtech Insight
  2. >>Policy & Regulation
  3. >>Compliance

J&J Subsidiary Pays $9.75M To Resolve Kickback Allegations

 
• By Elizabeth Orr

DePuy Synthes reportedly provided a Massachusetts surgeon with more than $100,000 in free implants and tools.

Johnson & Johnson subsidiary DePuy Synthes will pay $9.75m to resolve allegations that the company violated the False Claims Act by paying kickbacks to a Massachusetts-based orthopedic surgeon, the US Department of Justice announced on 20 January.

The government stated that DePuy gave the physician free spinal implants and tools for surgeries conducted overseas as a way...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Compliance

Global Medtech Guidance Tracker: May 2025

 
• By Vibha Sharma

Stay current on regulatory guidelines from around the world with Medtech Insight's Guidance Tracker. Thirty-six documents have been posted on the tracker since its last update.

FDA Rebukes Four Companies, Including One Overseas, For Procedural Failures

 
• By Brian Bossetta

The US FDA’s device center sent warning letters to three domestic device manufacturers and one German firm for failing to adhere to protocol on several issues.

Get Ready For International Harmonization Before Approaching QMSR Deadline, Says Regulatory Expert

 
• By Brian Bossetta

During MD&M East last week, regulatory consultant Darren Reeves reminded device manufacturers that the time to get ready to comply with the new Quality Management System Regulation is now.

FDA Draft Guidance Introduces Electric Submission For Q-Sub Process

 
• By Brian Bossetta

The US FDA says its updated draft guidance represents one of several steps the agency is taking to develop electronic submission templates for the medical device industry. The document introduces stakeholders to currently available resources for supporting their pre-subs to the agency.

More from Policy & Regulation